The flavonoid-like chemical compound Wogonin potentiated the inhibitory effect of Imatinib on leukemia development by suppressing STAT5 pathway in primary CML CD34+ cells [42]. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.